Feedback / Questions
FS001 - Ipsen
https://www.globenewswire.com/news-release/2024/07/11/2911523/0/en/Ipsen-and-Foreseen-Biotechnology-announce-exclusive-global-licensing-agreement-for-antibody-drug-conjugate-with-first-in-class-potential.html
 
Jul 11, 2024
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious